Key Takeaways Take-Two is set to report fiscal Q3 results on Feb. 3, guiding GAAP net revenues of $1.57B-$1.62B.TTWO faces pressure after Borderlands 4's Nintendo Switch 2 launch was delayed indefinitely in September.NBA 2K26 and GTA Online were expected to drive holiday engagement in a seasonally strong quarter for gaming.Take-Two Interactive Software (TTWO) is scheduled to release third-quarter fiscal 2026 results on Feb. 3.For the third quarter of fiscal 2026, Take-Two expects GAAP net revenues between $ ...

Core Insights - Essex Property Trust, Inc. (ESS) is expected to report its Q4 and full-year 2025 results on February 4, with anticipated year-over-year growth in revenues and core funds from operations (FFO) per share [1][10] Company Performance - In the last reported quarter, Essex Property achieved a core FFO per share surprise of 0.25%, driven by growth in same-property revenues and net operating income (NOI), although higher operating and interest expenses dampened results [2][10] - Over the past four quarters, Essex Property's earnings have consistently exceeded the Zacks Consensus Estimate, with an average surprise of 0.76% [3] Market Conditions - The US apartment market showed signs of softening in Q4 2025, with net move-outs of approximately 40,400 units, marking the first seasonal pullback in three years [4] - Supply pressures remain significant, with about 409,500 units delivered in 2025, including 89,400 in Q4, leading to a decline in occupancy to 94.8% and a 1.7% decrease in effective asking rents quarter-over-quarter [5] - Coastal and tech-oriented markets like New York and San Francisco continue to experience modest rent growth, while supply-heavy markets such as Austin and Phoenix face more significant rent pressures [6] Projections and Estimates - The Zacks Consensus Estimate for Essex Property's Q4 revenues is $476.57 million, reflecting a 4.86% year-over-year increase, with same-property revenues estimated at $414.75 million [9][10] - For Q4 2025, core FFO per share is projected to be between $3.93 and $4.03, with the consensus estimate remaining at $4.00, indicating a 2.04% year-over-year increase [11] - For full-year 2025, core FFO per share is expected to be in the range of $15.89 to $15.99, with a consensus estimate of $15.97, representing a 2.37% year-over-year increase on revenues of $1.88 billion [12] Challenges Ahead - Essex Property may face leasing challenges in Q4 due to elevated supply impacting rent growth and occupancy, alongside persistent higher interest expenses [8][10]

Key Takeaways EA is set to report fiscal Q3 results on Feb. 3, with EPS and revenues expected to rise.Electronic Arts' Battlefield 6 drove Q3, selling 7M units in three days with 172M matches opening weekend.EA's pending $55B buyout ended forward guidance, adding uncertainty around reporting.Electronic Arts (EA) is set to report third-quarter fiscal 2026 results on Feb. 3.The Zacks Consensus Estimate for earnings has remained steady at $4.77 per share in the past 30 days. The figure indicates a 68.55% incre ...

Key Takeaways CTVA is seeing strong performance in Crop Protection, driven by new products and volume growth.Corteva's Seed segment benefits from advanced genetics, higher out-licensing and execution across key markets.CTVA faces near-term risks from weak crop prices, pressured farm incomes and macro headwinds.Corteva, Inc. (CTVA) is slated to report fourth-quarter 2025 results on Feb. 3, after market close. The company is likely to report a bottom-line decline when it posts the quarterly results.The Zacks ...

Company Overview - Graham (GHM) is expected to report earnings for the quarter ended December 2025, with a consensus estimate of $0.17 per share, reflecting a year-over-year decline of 5.6% [3] - Revenues are anticipated to be $51.37 million, which represents a 9.2% increase from the previous year [3] Earnings Expectations - The earnings report is scheduled for release on February 6, and the stock price may rise if actual results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 2.95% over the last 30 days, indicating a bearish sentiment among analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model indicates that Graham has an Earnings ESP of -88.46%, suggesting analysts have become more pessimistic about the company's earnings prospects [12] - The stock currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [12] Historical Performance - In the last reported quarter, Graham was expected to post earnings of $0.33 per share but delivered $0.31, resulting in a surprise of -6.06% [13] - Over the past four quarters, Graham has beaten consensus EPS estimates three times [14] Industry Comparison - RBC Bearings (RBC), a peer in the Zacks Manufacturing - General Industrial industry, is expected to report earnings of $2.85 per share, reflecting a year-over-year increase of 21.8% [18] - RBC's revenues are projected to be $461.12 million, up 16.9% from the previous year, with a consensus EPS estimate revised 0.9% higher in the last 30 days [19]

Core Viewpoint - Frontier Group Holdings (ULCC) is expected to report a year-over-year decline in earnings due to lower revenues, with the consensus outlook being crucial for assessing the company's earnings picture [1] Earnings Expectations - The upcoming earnings report is anticipated to show quarterly earnings of $0.09 per share, reflecting a year-over-year decrease of 60.9% [3] - Revenues are projected to be $972.68 million, down 2.9% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 38.37% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4] - The Most Accurate Estimate for Frontier Group is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -14.26% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with significant predictive power for positive readings only [9][10] - Frontier Group's current Zacks Rank is 4, which complicates the prediction of an earnings beat [12] Historical Performance - In the last reported quarter, Frontier Group was expected to post a loss of $0.36 per share but delivered a loss of -$0.34, resulting in a surprise of +5.56% [13] - Over the past four quarters, the company has beaten consensus EPS estimates three times [14] Industry Comparison - Allegiant Travel (ALGT), another player in the airline industry, is expected to report earnings per share of $2.01 for the same quarter, indicating a year-over-year change of -4.3% [18] - Allegiant's revenues are expected to be $649.84 million, up 3.5% from the previous year, with a consensus EPS estimate revised down by 3.9% [19]

Core Viewpoint - MarketAxess (MKTX) is expected to report a year-over-year decline in earnings despite higher revenues for the quarter ended December 2025, with the consensus outlook being crucial for assessing the company's earnings picture [1] Earnings Expectations - The consensus EPS estimate for MarketAxess is $1.66 per share, reflecting a year-over-year decrease of 4.1% [3] - Revenues are anticipated to reach $212.7 million, which is a 5.1% increase from the same quarter last year [3] Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.06%, indicating a reassessment by analysts [4] - The Most Accurate Estimate for MarketAxess is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.05% [12] Earnings Surprise Potential - MarketAxess has a Zacks Rank of 3, suggesting a moderate outlook, but the positive Earnings ESP indicates a likelihood of beating the consensus EPS estimate [12] - The company has consistently beaten consensus EPS estimates in the past four quarters, with a notable surprise of +8.88% in the last reported quarter [13][14] Industry Context - Tradeweb Markets (TW), another player in the Zacks Financial - Investment Bank industry, is expected to post earnings of $0.85 per share for the same quarter, indicating a year-over-year increase of 11.8% [18] - Tradeweb's revenues are projected to be $516.57 million, up 11.5% from the previous year, but it has a negative Earnings ESP of -0.32% [19][20]

Key Takeaways PRU's U.S. business likely benefited from higher investment spread income and improved underwriting results. PGIM likely saw gains from higher asset management fees and stronger service revenues. PRU expenses likely increased due to higher policyholder benefits and deferred acquisition cost amortization. Prudential Financial Inc. (PRU) is expected to register an improvement in its top and bottom lines when it reports fourth-quarter 2025 results on Feb. 3, after the closing bell.The Zacks Conse ...

Core Insights - Kimball Electronics, Inc. (KE) is set to report its second-quarter fiscal 2026 results on February 4, with sales expected to decline by 4.2% year-over-year to $342.5 million and earnings estimated at 28 cents per share, reflecting a 3.5% decrease from the previous year [1][9]. Group 1: Earnings Performance - Kimball Electronics has consistently surpassed the Zacks Consensus Estimate in the last four quarters, with an average surprise of 49.71% [2]. - The current Earnings ESP for Kimball Electronics is 0.00%, and it holds a Zacks Rank of 3 (Hold), indicating uncertainty regarding an earnings beat this time [7]. Group 2: Factors Influencing Q2 Results - The company's second-quarter results are expected to benefit from its expansion in the high-growth medical contract manufacturing sector, particularly with a new 300,000 sq. ft. facility in Indianapolis [3]. - Demand for medical devices is driven by an aging population, increased healthcare access, and advancements in connected drug-delivery systems, which are anticipated to positively impact Kimball Electronics' performance [4]. - Operational improvements, including reduced inventory and lower selling, general, and administrative expenses, along with significant debt reduction, are likely to enhance the bottom line for the quarter [5]. Group 3: Industry Challenges - Despite the positive factors, overall results may be negatively impacted by industry-wide softness in the automotive and industrial segments, which could outweigh the strong performance in the medical division [6]. - The company's heavy reliance on a few large medical and automotive customers presents an additional concern [6].

Core Viewpoint - Bio-Techne Corporation (TECH) is expected to release its second-quarter fiscal 2026 results on February 4, with adjusted earnings per share (EPS) anticipated at 43 cents, reflecting a 2.4% increase from the previous year, while revenues are projected at $292 million, indicating a 1.7% decrease year-over-year [1][2]. Group 1: Earnings Performance - In the last reported quarter, Bio-Techne posted adjusted EPS of 42 cents, matching the Zacks Consensus Estimate, with the company beating earnings in three of the last four quarters and matching once, averaging a surprise of 6.58% [1]. - Estimates for earnings have remained constant at 43 cents over the past 30 days, indicating stability in expectations leading up to the announcement [3]. Group 2: Revenue Estimates - The Zacks Consensus Estimate for revenues is set at $292 million, which represents a decrease of 1.7% from the year-ago figure [2]. - The consensus estimate for the Spatial Biology segment's revenues is pegged at $81.6 million, down 3% from the previous year [15]. Group 3: Factors Influencing Performance - Ongoing macro uncertainties, including tariffs and potential NIH budget cuts, may add to customer uncertainty and temporarily slow growth momentum in the second quarter of fiscal 2026 [4]. - The timing related to cell therapy programs negatively impacted sales in the previous quarter, and this trend is expected to continue [5]. - The core portfolio of research-use-only proteomic agents, featuring over 6,000 proteins and 400,000 antibody types, is likely to support global customers in advancing therapeutics for precision diagnostics [6]. Group 4: Segment Developments - The protein analytical instrumentation business is expected to maintain strong momentum, with the ProteinSimple solution resuming double-digit growth [7]. - Demand for the next-generation high-throughput instrument, Leo, appears to be strong, contributing positively to quarterly results [8]. - Major developments include a licensing agreement with Monod Bio for exclusive rights to a subset of AI-designed bispecific binding proteins and a strategic distribution partnership with Sphere Bio for ultrasensitive immunoassays targeting Alzheimer's biomarkers [10]. Group 5: Challenges and Growth Areas - The Spatial Biology segment may face revenue declines due to the divestiture of the Exosome Diagnostics business, despite growth in the RNAscope product suite [12]. - The segment is likely to encounter headwinds from NIH funding uncertainties and a weaker biotech funding environment [13]. - The company has launched several new products and partnerships aimed at enhancing its offerings in spatial biology and diagnostics, which may contribute to top-line performance [14].